News for Iovance Biotherapeutics, Inc. (0JDK.L)

NEW YORK, June 08, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Bio

BENSALEM, Pa., June 04, 2025 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shar

LOS ANGELES, May 29, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of share

NEW YORK, May 27, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biot

NEW YORK, May 25, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biot

NEW YORK, May 23, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biot

LOS ANGELES, May 22, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of share

NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biot

PR NewswireNEW YORK, May 19, 2025 NEW YORK, May 19, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Iovance Biothera

IOVA Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO, May 19, 2025 (GLOBE NEWSWIRE) -- Biotechnology firm Iovance Biotherapeutics, I

[url="]The Law Offices of Frank R. Cruz[/url] announces that a class action lawsuit has been filed on behalf of investors who purchased Iovance Biotherapeutics

PR NewswireNEW YORK, May 19, 2025 NEW YORK, May 19, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces that a shareholder fi

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on beha

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Iovance Biotherapeutics, Inc. (”œIovance” or th

PR NewswireNEW YORK, May 17, 2025 NEW YORK, May 17, 2025 /PRNewswire/ -- Julie & Holleman LLP, a top-tier shareholder rights firm, is investigating potenti

On May 14, 2025, Frederick Vogt, Interim Chief Executive Officer and General Counsel at Iovance Biotherapeutics Inc (IOVA), purchased 25,000 shares of the compa

PR NewswireSAN DIEGO, May 16, 2025 SAN DIEGO, May 16, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all

We recently published a list of 10 Best Low Priced Biotech Stocks to Buy Now. In this article, we are going to take a look at where Iovance Biotherapeutics, Inc.

NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Iovance Biotherapeutics, Inc. (”œIov